Asthma, asthma control and risk of acute myocardial infarction: HUNT study

被引:0
|
作者
Aivaras Cepelis
Ben M. Brumpton
Lars E. Laugsand
Håvard Dalen
Arnulf Langhammer
Imre Janszky
Linn B. Strand
机构
[1] NTNU,Department of Public Health and Nursing, Faculty of Medicine and Health Science
[2] Norwegian University of Science and Technology,Department of Thoracic and Occupational Medicine
[3] St. Olavs Hospital,K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing
[4] Trondheim University Hospital,MRC Integrative Epidemiology Unit, School of Social and Community Medicine
[5] NTNU,Department of Emergency Medicine
[6] Norwegian University of Science and Technology,Department of Medicine
[7] University of Bristol,Department of Circulation and Medical Imaging
[8] St. Olavs Hospital,Cardiac Clinic
[9] Levanger Hospital,Department of Neurology, Medical School
[10] Nord-Trøndelag Hospital Trust,undefined
[11] NTNU,undefined
[12] Norwegian University of Science and Technology,undefined
[13] St. Olavs Hospital,undefined
[14] Trondheim University Hospital,undefined
[15] University of Pécs,undefined
来源
关键词
Myocardial infarction; Heart attack; Cardiovascular disease; Asthma; Asthma control;
D O I
暂无
中图分类号
学科分类号
摘要
Asthma, a chronic inflammatory airway disease, shares several common pathophysiological mechanisms with acute myocardial infarction (AMI). Our aim was to assess the prospective associations between asthma, levels of asthma control and risk of AMI. We followed 57,104 adults without previous history of AMI at baseline from Nord-Trøndelag health study (HUNT) in Norway. Self-reported asthma was categorised as active asthma (i.e., using asthma medication) and non-active asthma (i.e., not using asthma medication). Levels of asthma control were defined as controlled, partly controlled, and uncontrolled based on the Global Initiative for Asthma guidelines. AMI was ascertained by linking HUNT data with hospital records. A total of 2868 AMI events (5.0%) occurred during a mean (SD) follow-up of 17.2 (5.4) years. Adults with active asthma had an estimated 29% higher risk of developing AMI [adjusted hazard ratio (HR) 1.29, 95% CI 1.08–1.54] compared with adults without asthma. There was a significant dose–response association between asthma control and AMI risk, with highest risk in adults with uncontrolled asthma (adjusted HR 1.73, 95% CI 1.13–2.66) compared to adults with controlled asthma (p for trend < 0.05). The associations were not explained by smoking status, physical activity and C-reactive protein levels. Our study suggests that active asthma and poor asthma control are associated with moderately increased risk of AMI. Further studies are needed to evaluate causal relationship and the underlying mechanisms and to clarify the role of asthma medications in the risk of AMI.
引用
收藏
页码:967 / 977
页数:10
相关论文
共 50 条
  • [41] Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case–control study
    F F Alharbi
    P C Souverein
    M C de Groot
    A H Maitland-van der Zee
    A de Boer
    O H Klungel
    Journal of Human Hypertension, 2017, 31 : 537 - 544
  • [42] Case-control study of passive smoking at home and risk of acute myocardial infarction
    Ciruzzi, M
    Pramparo, P
    Esteban, O
    Rozlosnik, J
    Tartaglione, J
    Abecasis, B
    César, J
    De Rosa, J
    Paterno, C
    Schargrodsky, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (04) : 797 - 803
  • [43] Lipoprotein subfraction profiling in the search of new risk markers for myocardial infarction: The HUNT study
    Sperstad, Sigri Bakken
    Saether, Julie Caroline
    Klevjer, Marie
    Giskeodegard, Guro Fannelob
    Bathen, Tone Frost
    Rosbjorgen, Ragnhild
    Dalen, Havard
    Bye, Anja
    PLOS ONE, 2023, 18 (05):
  • [44] The Pattern of Risk of Myocardial Infarction in Patients Taking Asthma Medication: A Study with the UK General Practice Research Database (GPRD)
    Zhang, Bill
    de Vries, Frank
    Setakis, Efrosini
    van Staa, Tjeerd-Pieter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S209 - S209
  • [45] Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation
    Meltzer, Eli O.
    Busse, William W.
    Wenzel, Sally E.
    Belozeroff, Vasily
    Weng, Haoling H.
    Feng, JingYuan
    Chon, Yun
    Chiou, Chiun-Fang
    Globe, Denise
    Lin, Shao-Lee
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (01) : 167 - 172
  • [46] Maternal asthma severity and control during pregnancy and risk of offspring asthma
    Liu, Xiaoqin
    Agerbo, Esben
    Schlunssen, Vivi
    Wright, Rosalind J.
    Li, Jiong
    Munk-Olsen, Trine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (03) : 886 - +
  • [47] Maternal asthma and risk of preeclampsia - A case-control study
    Rudra, CB
    Williams, MA
    Frederick, IO
    Luthy, DA
    JOURNAL OF REPRODUCTIVE MEDICINE, 2006, 51 (02) : 94 - 100
  • [48] CARDIAC ASTHMA AND MYOCARDIAL-INFARCTION IN HYPERTENSIVE CARDIAC CRISIS
    MOISEEV, SG
    SOVETSKAYA MEDITSINA, 1974, (09): : 18 - 21
  • [49] Risk factors for near-fatal asthma - A case-control study in hospitalized patients with asthma
    Turner, MO
    Noertjojo, K
    Vedal, S
    Bai, T
    Crump, S
    FitzGerald, JM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) : 1804 - 1809
  • [50] Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study
    Brumpton, Ben M.
    Langhammer, Arnulf
    Henriksen, Anne H.
    Romundstad, Pal R.
    Chen, Yue
    Camargo, Carlos A., Jr.
    Mai, Xiao-Mei
    RESPIRATORY MEDICINE, 2018, 136 : 65 - 70